148 related articles for article (PubMed ID: 29509280)
1. Prognostic importance of solid variant papillary thyroid carcinoma: A systematic review and meta-analysis.
Vuong HG; Odate T; Duong UNP; Mochizuki K; Nakazawa T; Katoh R; Kondo T
Head Neck; 2018 Jul; 40(7):1588-1597. PubMed ID: 29509280
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of diffuse sclerosing variant papillary thyroid carcinoma: a systematic review and meta-analysis.
Vuong HG; Kondo T; Pham TQ; Oishi N; Mochizuki K; Nakazawa T; Hassell L; Katoh R
Eur J Endocrinol; 2017 Apr; 176(4):433-441. PubMed ID: 28183787
[TBL] [Abstract][Full Text] [Related]
3. Cytopathology of Solid Variant of Papillary Thyroid Carcinoma: Differential Diagnoses with other Thyroid Tumors.
Guleria P; Phulware R; Agarwal S; Jain D; Mathur SR; Iyer VK; Ballal S; Bal CS
Acta Cytol; 2018; 62(5-6):371-379. PubMed ID: 30253413
[TBL] [Abstract][Full Text] [Related]
4. Solid variant of papillary thyroid carcinoma: An analysis of 28 cases with current literature.
Vural Ç; Kiraz U; Turan G; Özkara SK; Sözen M; Çetinarslan B
Ann Diagn Pathol; 2021 Jun; 52():151737. PubMed ID: 33838489
[TBL] [Abstract][Full Text] [Related]
5. A comparison of the clinicopathological features and prognoses of the classical and the tall cell variant of papillary thyroid cancer: a meta-analysis.
Liu Z; Zeng W; Chen T; Guo Y; Zhang C; Liu C; Huang T
Oncotarget; 2017 Jan; 8(4):6222-6232. PubMed ID: 28009980
[TBL] [Abstract][Full Text] [Related]
6. Solid variant of papillary thyroid carcinoma: an under-recognized entity.
Ohashi R
Endocr J; 2020 Mar; 67(3):241-248. PubMed ID: 31983699
[TBL] [Abstract][Full Text] [Related]
7. Differential Clinicopathological Risk and Prognosis of Major Papillary Thyroid Cancer Variants.
Shi X; Liu R; Basolo F; Giannini R; Shen X; Teng D; Guan H; Shan Z; Teng W; Musholt TJ; Al-Kuraya K; Fugazzola L; Colombo C; Kebebew E; Jarzab B; Czarniecka A; Bendlova B; Sykorova V; Sobrinho-Simões M; Soares P; Shong YK; Kim TY; Cheng S; Asa SL; Viola D; Elisei R; Yip L; Mian C; Vianello F; Wang Y; Zhao S; Oler G; Cerutti JM; Puxeddu E; Qu S; Wei Q; Xu H; O'Neill CJ; Sywak MS; Clifton-Bligh R; Lam AK; Riesco-Eizaguirre G; Santisteban P; Yu H; Tallini G; Holt EH; Vasko V; Xing M
J Clin Endocrinol Metab; 2016 Jan; 101(1):264-74. PubMed ID: 26529630
[TBL] [Abstract][Full Text] [Related]
8. Impact of tall cell variant histology on predicting relapse and changing the management of papillary thyroid carcinoma patients.
Gunalp B; Okuyucu K; Ince S; Ayan A; Alagoz E
Hell J Nucl Med; 2017; 20(2):122-127. PubMed ID: 28697188
[TBL] [Abstract][Full Text] [Related]
9. Fine-needle aspiration cytology of the solid variant of papillary thyroid carcinoma: a study of 13 cases with clinical, histologic, and ultrasound correlations.
Giorgadze TA; Scognamiglio T; Yang GC
Cancer Cytopathol; 2015 Feb; 123(2):71-81. PubMed ID: 25572906
[TBL] [Abstract][Full Text] [Related]
10. Do aggressive variants of papillary thyroid carcinoma have worse clinical outcome than classic papillary thyroid carcinoma?
Song E; Jeon MJ; Oh HS; Han M; Lee YM; Kim TY; Chung KW; Kim WB; Shong YK; Song DE; Kim WG
Eur J Endocrinol; 2018 Sep; 179(3):135-142. PubMed ID: 29875289
[TBL] [Abstract][Full Text] [Related]
11. Survival of aggressive variants of papillary thyroid carcinoma in patients under 55 years old: a SEER population-based retrospective analysis.
Feng J; Shen F; Cai W; Gan X; Deng X; Xu B
Endocrine; 2018 Sep; 61(3):499-505. PubMed ID: 29909599
[TBL] [Abstract][Full Text] [Related]
12. A diffuse sclerosing variant of papillary thyroid carcinoma: clinical and pathologic features and outcomes of 34 consecutive cases.
Regalbuto C; Malandrino P; Tumminia A; Le Moli R; Vigneri R; Pezzino V
Thyroid; 2011 Apr; 21(4):383-9. PubMed ID: 21309722
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological significance of a solid component in papillary thyroid carcinoma.
Ohashi R; Kawahara K; Namimatsu S; Igarashi T; Sakatani T; Sugitani I; Naito Z
Histopathology; 2017 Apr; 70(5):775-781. PubMed ID: 27882585
[TBL] [Abstract][Full Text] [Related]
14. Role of molecular markers to predict distant metastasis in papillary thyroid carcinoma: Promising value of TERT promoter mutations and insignificant role of BRAF mutations-a meta-analysis.
Vuong HG; Altibi AM; Duong UN; Ngo HT; Pham TQ; Tran HM; Oishi N; Mochizuki K; Nakazawa T; Hassell L; Katoh R; Kondo T
Tumour Biol; 2017 Oct; 39(10):1010428317713913. PubMed ID: 29037127
[TBL] [Abstract][Full Text] [Related]
15. The value of preoperative antithyroidperoxidase antibody as a novel predictor of recurrence in papillary thyroid carcinoma.
Song E; Oh HS; Jeon MJ; Chung KW; Hong SJ; Ryu JS; Baek JH; Lee JH; Kim WG; Kim WB; Shong YK; Kim TY
Int J Cancer; 2019 Mar; 144(6):1414-1420. PubMed ID: 30357831
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Value of Extranodal Extension in Thyroid Cancer: A Meta-Analysis.
Suh S; Pak K; Seok JW; Kim IJ
Yonsei Med J; 2016 Nov; 57(6):1324-8. PubMed ID: 27593858
[TBL] [Abstract][Full Text] [Related]
17. Association of Multifocality With Prognosis of Papillary Thyroid Carcinoma: A Systematic Review and Meta-analysis.
Kim H; Kwon H; Moon BI
JAMA Otolaryngol Head Neck Surg; 2021 Oct; 147(10):847-854. PubMed ID: 34410321
[TBL] [Abstract][Full Text] [Related]
18. Papillary thyroid carcinoma with tall cell features is as aggressive as tall cell variant: a meta-analysis.
Vuong HG; Long NP; Anh NH; Nghi TD; Hieu MV; Hung LP; Nakazawa T; Katoh R; Kondo T
Endocr Connect; 2018 Dec; 7(12):R286-R293. PubMed ID: 30352403
[TBL] [Abstract][Full Text] [Related]
19. The Prognostic Value of Tumor Multifocality in Clinical Outcomes of Papillary Thyroid Cancer.
Wang F; Yu X; Shen X; Zhu G; Huang Y; Liu R; Viola D; Elisei R; Puxeddu E; Fugazzola L; Colombo C; Jarzab B; Czarniecka A; Lam AK; Mian C; Vianello F; Yip L; Riesco-Eizaguirre G; Santisteban P; O'Neill CJ; Sywak MS; Clifton-Bligh R; Bendlova B; Sýkorová V; Wang Y; Liu S; Zhao J; Zhao S; Xing M
J Clin Endocrinol Metab; 2017 Sep; 102(9):3241-3250. PubMed ID: 28582521
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathologic features of solid variant papillary thyroid cancer.
Chang H; Kim SM; Chun KW; Kim BW; Lee YS; Chang HS; Hong SW; Park CS
ANZ J Surg; 2014 May; 84(5):380-2. PubMed ID: 23826897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
